VANCOUVER, British Columbia (09/21/06) -- Wataire Industries Inc. (Pink Sheets:WTAF) announces it has converted a provisional patent application to a regular US patent application titled "Water Treatment processes and devices for water-from-air machines." Wataire's Research and Development Division has been working for several years to provide an effective and reliable method of controlling bacterial colonies attached to solid surfaces inside water systems.

In municipal systems chlorine is used to control bacterial growth. Water-from-air machines, especially residential sized machines, are not suited for addition of chlorine, a powerful chemical requiring special handling conditions. Much of the marketing appeal of water-from-air machines is the avoidance of any water treatment chemicals.

Micro-organisms, with Wataire's innovative design, are effectively managed the moment they enter Wataire's water treatment apparatus.

In addition to effectively controlling biofilm, Wataire's design combines innovations in the storage, treatment and dispensing of safe drinking water for both Wataire's counter top appliance as well as the Company's commercial size machines that produce 2500 and 5000 litres per day.

In a number of different locations and climates around the world, Wataire has conducted independent lab tests to determine the ability of Wataire machines to control biofilm and ensure its drinking water meets World Health Organization guidelines. In every instance, these guidelines have been met or exceeded.

Wataire's patent application for biofilm control is one of several technical advances being pursued by the Company whose goal is to continue as an industry pioneer in the growing air-to-water industry.

Forward Looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's Dependence on third-party suppliers and other risks, detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.